Caroline Young, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 121 shares at $3.34 ($398) on 2025-08-06, disclosed to the SEC on 2025-09-12.
Scheduled purchase ($398) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.44 | 6 | $21 | 5.2% |
| 2 | $4.01 | 6 | $24 | 6.0% |
| 3 | $3.92 | 6 | $24 | 5.9% |
| 4 | $3.34 | 6 | $20 | 5.0% |
| 5 | $3.14 | 6 | $19 | 4.7% |
| 6 | $3.39 | 6 |
| $20 |
| 5.1% |
| 7 | $2.87 | 6 | $17 | 4.3% |
| 8 | $2.91 | 6 | $17 | 4.4% |
| 9 | $2.94 | 6 | $18 | 4.4% |
| 10 | $2.84 | 6 | $17 | 4.3% |
| 11 | $3.02 | 6 | $18 | 4.6% |
| 12 | $3.11 | 6 | $19 | 4.7% |
| 13 | $3.23 | 6 | $19 | 4.9% |
| 14 | $3.15 | 1 | $3 | 0.8% |
| 15 | $3.25 | 6 | $20 | 4.9% |
| 16 | $3.31 | 6 | $20 | 5.0% |
| 17 | $3.32 | 6 | $20 | 5.0% |
| 18 | $3.39 | 6 | $20 | 5.1% |
| 19 | $3.44 | 6 | $21 | 5.2% |
| 20 | $3.47 | 6 | $21 | 5.2% |
| 21 | $3.45 | 6 | $21 | 5.2% |
| Total | $3.29 avg | 121 | $398 | 100% |
| Filing → |
| CPIX | BUY | 2025-06-06 | $429 | — | Filing → |
| CPIX | BUY | 2025-05-09 | $417 | — | Filing → |
| CPIX | BUY | 2025-04-04 | $384 | — | Filing → |